Skip to main content
Veterinary Medicines

TENIVERM 0,5 CAPSULE

Authorised
  • Levamisole hydrochloride
  • Niclosamide

Product identification

Medicine name:
TENIVERM 0,5 CAPSULE
Active substance:
  • Levamisole hydrochloride
  • Niclosamide
Target species:
  • Pigeon
  • Ornamental bird
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Levamisole hydrochloride
    12.02
    milligram(s)
    /
    1.00
    Capsule
  • Niclosamide
    48.00
    milligram(s)
    /
    1.00
    Capsule
Pharmaceutical form:
  • Capsule, soft
Withdrawal period by route of administration:
  • Oral use
    • Pigeon
      • All relevant tissues
        no withdrawal period
    • Ornamental bird
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AE51
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • ARRIGONI Patrice Antoine Gaston
Marketing authorisation date:
Manufacturing sites for batch release:
  • LABORATOIRES BIOVE
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/9855777 2/1984
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 11/02/2025

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 11/02/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."